Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC
- Status
- COMPLETED
- Phase
- PHASE1
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
- Status
- COMPLETED
- Phase
- PHASE2
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
- Status
- TERMINATED
- Phase
- PHASE2
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3